Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Pollen-Induced Allergic Bronchial Asthma in a Mouse Model.

Wormwood () pollen is among the top 10 aeroallergens globally that cause allergic rhinitis and bronchial asthma. Allergen-specific immunotherapy (ASIT) is the gold standard for treating patients with allergic rhinitis, conjunctivitis, and asthma. A significant disadvantage of today's ASIT methods is the long duration of therapy and multiplicity of allergen administrations.